Moderate or severe renal impairment. Monitor renal function. Avoid concomitant nephrotoxic drugs. Antiretroviral-experienced patients harbouring K65R mutation strains. Decrease in bone mineral density. Co-infection w/ hepatitis B or C. Risk factors for liver disease & hepatic steatosis. Lipodystrophy. Pregnancy & lactation. Childn <18 yr.